brexucabtagene autoleucel
gilead sciences
['mantle,(-dismantle)', 'cart,(-cartitude)', 'lymphoma', 'zuma-2']
3-year follow-up of kte-x19 in patients with relapsed/refractory mantle cell lymphoma, including high-risk subgroups, in the zuma-2 study #cart #bmtsm #cartcell #immunotherapy #tcellrx #ican #crs #cartcells #celltherapy 
Cellular Therapy Program @ KFSHRC KSA #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS  #CARTcells #CellTherapy #Gene #Genetherapy @ASTCT